Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Uridine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A1 | O00337 | 1/20 | 0.88 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.88 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.88 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.88 |
| ▸ | P2RY2 | P41231 | 11/20 | 0.72 |
| ▸ | P2RY6 | Q15077 | 8/20 | 0.68 |
| ▸ | P2RY4 | P51582 | 4/20 | 0.67 |
| ▸ | P2RY14 | Q15391 | 7/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Uridine SCHEMBL30094506 | 0.99 | SLC28A1 (0.90) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL29801499 | 0.99 | SLC28A1 (0.90) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL28065954 | 0.99 | SLC28A1 (0.90) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL376208 | 0.99 | SLC28A1 (0.90) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL76681 | 0.99 | SLC28A1 (0.90) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL157643 | 0.99 | SLC28A1 (0.90) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL28131489 | 0.97 | SLC28A1 (0.88) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL17074124 | 0.97 | SLC28A1 (0.88) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL29474873 | 0.95 | SLC28A1 (0.97) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL29361169 | 0.95 | SLC28A1 (0.97) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230293567-A1 | Product and method for increasing uridine concentration in blood plasma | N.V. NUTRICIA (NL) | 2023-09-21 | — | — | US | claimed |
| EP-4183398-A1 | COMBINATIONS OF URIDINE AND SODIUM FOR INCREASING URIDINE CONCENTRATION IN BLOOD PLASMA | N.V. Nutricia (NL) | 2023-05-24 | — | — | EP | claimed |
| EP-2544553-B2 | CONTROLLING THE TEXTURE OF HIGH-PROTEIN NUTRITIONAL COMPOSITIONS COMPRISING MICELLAR CASEIN | NUTRICIA NV (NL) | 2022-11-09 | — | — | EP | claimed |
| CN-106928269-B | Preparation method of phosphate | 长春普华制药股份有限公司 | 2020-03-24 | — | — | CN | claimed |
| EP-3503899-A1 | PRODUCT AND METHOD FOR INCREASING URIDINE CONCENTRATION IN BLOOD PLASMA | N.V. Nutricia (NL) | 2019-07-03 | — | — | EP | claimed |
| WO-2018038599-A1 | PRODUCT AND METHOD FOR INCREASING URIDINE CONCENTRATION IN BLOOD PLASMA | N.V. NUTRICIA (NL) | 2018-03-01 | — | — | WO | claimed |
| WO-2018038609-A1 | PRODUCT AND METHOD FOR INCREASING URIDINE CONCENTRATION IN BLOOD PLASMA | N.V. NUTRICIA (NL) | 2018-03-01 | — | — | WO | claimed |
| US-9872888-B2 | Use of a nucleotide for improving the heat stability of an aqueous micellar casein composition | N.V. NUTRICIA (NL) | 2018-01-23 | — | — | US | claimed |
| EP-2732710-B1 | Controlling the texture of high-protein nutritional compositions comprising micellar casein | NUTRICIA NV (NL) | 2015-07-29 | — | — | EP | claimed |
| EP-2734060-A1 | USE OF A NUCLEOTIDE FOR IMPROVING THE HEAT STABILITY OF AN AQUEOUS MICELLAR CASEIN COMPOSITION | N.V. Nutricia (NL) | 2014-05-28 | — | — | EP | claimed |
| EP-2732710-A1 | Controlling the texture of high-protein nutritional compositions comprising micellar casein | N.V. Nutricia (NL) | 2014-05-21 | — | — | EP | claimed |
| US-20140135257-A1 | USE OF A NUCLEOTIDE FOR IMPROVING THE HEAT STABILITY OF AN AQUEOUS MICELLAR CASEIN COMPOSITION | N.V. NUTRICIA | 2014-05-15 | — | — | US | claimed |
| EP-2544553-B1 | CONTROLLING THE TEXTURE OF HIGH-PROTEIN NUTRITIONAL COMPOSITIONS COMPRISING MICELLAR CASEIN | NUTRICIA NV (NL) | 2014-02-26 | — | — | EP | claimed |
| US-20130065824-A1 | CONTROLLING THE TEXTURE OF HIGH-PROTEIN NUTRITIONAL COMPOSITIONS COMPRISING MICELLAR CASEIN | N.V. NUTRICIA | 2013-03-14 | — | — | US | claimed |
| WO-2013012313-A1 | USE OF A NUCLEOTIDE FOR IMPROVING THE HEAT STABILITY OF AN AQUEOUS MICELLAR CASEIN COMPOSITION | N.V. NUTRICIA (NL) | 2013-01-24 | — | — | WO | claimed |
| WO-2013012324-A1 | USE OF A NUCLEOTIDE FOR IMPROVING THE HEAT STABILITY OF AN AQUEOUS MICELLAR CASEIN COMPOSITION | N.V. NUTRICIA (NL) | 2013-01-24 | — | — | WO | claimed |
| EP-2544553-A1 | CONTROLLING THE TEXTURE OF HIGH-PROTEIN NUTRITIONAL COMPOSITIONS COMPRISING MICELLAR CASEIN | N.V. Nutricia (NL) | 2013-01-16 | — | — | EP | claimed |
| WO-2011112075-A1 | CONTROLLING THE TEXTURE OF HIGH-PROTEIN NUTRITIONAL COMPOSITIONS COMPRISING MICELLAR CASEIN | N.V. NUTRICIA (NL) | 2011-09-15 | — | — | WO | claimed |
| WO-2011112087-A1 | CONTROLLING THE TEXTURE OF HIGH-PROTEIN NUTRITIONAL COMPOSITIONS COMPRISING MICELLAR CASEIN | N.V. NUTRICIA (NL) | 2011-09-15 | — | — | WO | claimed |
| EP-4353261-A1 | NUTRACEUTIC COMBINATION AND ITS USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS | Hospital Sant Joan de Deu (ES) | 2024-04-17 | — | — | EP | disclosed |
| CN-113784706-B | Multi-layered pharmaceutical or nutraceutical solid dosage forms comprising pyrimidine and/or purine derivatives and B vitamins, their preparation and use | 菲尔若国际公司 | 2024-01-05 | — | — | CN | disclosed |
| US-20240000124-A1 | DAIRY PRODUCT AND PROCESS | FONTERRA COOPERATIVE GROUP LTD (NZ) | 2024-01-04 | — | — | US | disclosed |
| US-20230293567-A1 | Product and method for increasing uridine concentration in blood plasma | N.V. NUTRICIA (NL) | 2023-09-21 | — | — | US | disclosed |
| CN-116768948-A | Method for synthesizing urine phosphorylcholine in citicoline injection | 山东玉满坤生物科技有限公司 | 2023-09-19 | — | — | CN | disclosed |
| CN-116768948-A | Method for synthesizing urine phosphorylcholine in citicoline injection | 山东玉满坤生物科技有限公司 | 2023-09-19 | — | — | CN | disclosed |
| EP-4228417-A1 | DAIRY PRODUCT AND PROCESS | Fonterra Co-Operative Group Limited (NZ) | 2023-08-23 | — | — | EP | disclosed |
| US-11707478-B2 | Method for increasing uridine concentration in blood plasma | N.V. NUTRICIA (NL) | 2023-07-25 | — | — | US | disclosed |
| CN-116284187-A | Method for synthesizing urine phosphorylcholine in citicoline injection | 山东玉满坤生物科技有限公司 | 2023-06-23 | — | — | CN | disclosed |
| EP-4183398-A1 | COMBINATIONS OF URIDINE AND SODIUM FOR INCREASING URIDINE CONCENTRATION IN BLOOD PLASMA | N.V. Nutricia (NL) | 2023-05-24 | — | — | EP | disclosed |
| CN-115916151-A | Expanded foams for delivery of functional ingredients | 勃林格殷格翰动物保健有限公司 | 2023-04-04 | — | — | CN | disclosed |
| EP-3503899-B1 | PRODUCT AND METHOD FOR INCREASING URIDINE CONCENTRATION IN BLOOD PLASMA | NUTRICIA NV (NL) | 2022-11-23 | — | — | EP | disclosed |
| EP-2544553-B2 | CONTROLLING THE TEXTURE OF HIGH-PROTEIN NUTRITIONAL COMPOSITIONS COMPRISING MICELLAR CASEIN | NUTRICIA NV (NL) | 2022-11-09 | — | — | EP | disclosed |
| CN-111662350-B | Preparation method of green intelligent high-purity diquafosol tetrasodium | 南京宸翔医药研究有限责任公司 | 2022-06-07 | — | — | CN | disclosed |
| CN-111662350-B | Preparation method of green intelligent high-purity diquafosol tetrasodium | 南京宸翔医药研究有限责任公司 | 2022-06-07 | — | — | CN | disclosed |
| CN-109789161-B | Products and methods for increasing uridine concentration in plasma | N·V·努特里奇亚 | 2022-04-22 | — | — | CN | disclosed |
| WO-2022079673-A1 | DAIRY PRODUCT AND PROCESS | FONTERRA CO-OPERATIVE GROUP LIMITED (NZ) | 2022-04-21 | — | — | WO | disclosed |
| CN-111662350-A | Preparation method of green intelligent high-purity diquafosol tetrasodium | 南京宸翔医药研究有限责任公司 | 2020-09-15 | — | — | CN | disclosed |
| CN-111662350-A | Preparation method of green intelligent high-purity diquafosol tetrasodium | 南京宸翔医药研究有限责任公司 | 2020-09-15 | — | — | CN | disclosed |
| CN-110944622-A | External composition | 大塚制药株式会社 | 2020-03-31 | — | — | CN | disclosed |
| EP-3503899-A1 | PRODUCT AND METHOD FOR INCREASING URIDINE CONCENTRATION IN BLOOD PLASMA | N.V. Nutricia (NL) | 2019-07-03 | — | — | EP | disclosed |
| US-20190183916-A1 | PRODUCT AND METHOD FOR INCREASING URIDINE CONCENTRATION IN BLOOD PLASMA | N.V. NUTRICIA (NL) | 2019-06-20 | — | — | US | disclosed |
| US-10264806-B2 | Controlling the texture of high-protein nutritional compositions comprising micellar casein | N.V. NUTRICIA (NL) | 2019-04-23 | — | — | US | disclosed |
| WO-2018038599-A1 | PRODUCT AND METHOD FOR INCREASING URIDINE CONCENTRATION IN BLOOD PLASMA | N.V. NUTRICIA (NL) | 2018-03-01 | — | — | WO | disclosed |
| WO-2018038609-A1 | PRODUCT AND METHOD FOR INCREASING URIDINE CONCENTRATION IN BLOOD PLASMA | N.V. NUTRICIA (NL) | 2018-03-01 | — | — | WO | disclosed |
| US-9872888-B2 | Use of a nucleotide for improving the heat stability of an aqueous micellar casein composition | N.V. NUTRICIA (NL) | 2018-01-23 | — | — | US | disclosed |
| EP-2734060-B1 | USE OF A NUCLEOTIDE FOR IMPROVING THE HEAT STABILITY OF AN AQUEOUS MICELLAR CASEIN COMPOSITION | NUTRICIA NV (NL) | 2017-11-29 | — | — | EP | disclosed |
| EP-2732710-B1 | Controlling the texture of high-protein nutritional compositions comprising micellar casein | NUTRICIA NV (NL) | 2015-07-29 | — | — | EP | disclosed |
| EP-2734060-A1 | USE OF A NUCLEOTIDE FOR IMPROVING THE HEAT STABILITY OF AN AQUEOUS MICELLAR CASEIN COMPOSITION | N.V. Nutricia (NL) | 2014-05-28 | — | — | EP | disclosed |
| EP-2732710-A1 | Controlling the texture of high-protein nutritional compositions comprising micellar casein | N.V. Nutricia (NL) | 2014-05-21 | — | — | EP | disclosed |
| US-20140135257-A1 | USE OF A NUCLEOTIDE FOR IMPROVING THE HEAT STABILITY OF AN AQUEOUS MICELLAR CASEIN COMPOSITION | N.V. NUTRICIA | 2014-05-15 | — | — | US | disclosed |
| EP-2544553-B1 | CONTROLLING THE TEXTURE OF HIGH-PROTEIN NUTRITIONAL COMPOSITIONS COMPRISING MICELLAR CASEIN | NUTRICIA NV (NL) | 2014-02-26 | — | — | EP | disclosed |
| US-20130065824-A1 | CONTROLLING THE TEXTURE OF HIGH-PROTEIN NUTRITIONAL COMPOSITIONS COMPRISING MICELLAR CASEIN | N.V. NUTRICIA | 2013-03-14 | — | — | US | disclosed |
| WO-2013012313-A1 | USE OF A NUCLEOTIDE FOR IMPROVING THE HEAT STABILITY OF AN AQUEOUS MICELLAR CASEIN COMPOSITION | N.V. NUTRICIA (NL) | 2013-01-24 | — | — | WO | disclosed |
| WO-2013012324-A1 | USE OF A NUCLEOTIDE FOR IMPROVING THE HEAT STABILITY OF AN AQUEOUS MICELLAR CASEIN COMPOSITION | N.V. NUTRICIA (NL) | 2013-01-24 | — | — | WO | disclosed |
| EP-2544553-A1 | CONTROLLING THE TEXTURE OF HIGH-PROTEIN NUTRITIONAL COMPOSITIONS COMPRISING MICELLAR CASEIN | N.V. Nutricia (NL) | 2013-01-16 | — | — | EP | disclosed |
| WO-2011112075-A1 | CONTROLLING THE TEXTURE OF HIGH-PROTEIN NUTRITIONAL COMPOSITIONS COMPRISING MICELLAR CASEIN | N.V. NUTRICIA (NL) | 2011-09-15 | — | — | WO | disclosed |
| WO-2011112087-A1 | CONTROLLING THE TEXTURE OF HIGH-PROTEIN NUTRITIONAL COMPOSITIONS COMPRISING MICELLAR CASEIN | N.V. NUTRICIA (NL) | 2011-09-15 | — | — | WO | disclosed |
| US-6194009-B1 | INSTANT FOODS; LINOLEIC AND LINOLENIC ACIDS; NUTRITIONALLY BALANCED | PRINCETON NUTRITION, LLC | 2001-02-27 | — | — | US | disclosed |
| WO-1998006277-A1 | NUTRITIONAL FORMULAS SUPPLEMENTED WITH NUCLEOTIDES, AND PROCESSES THEREOF | BRISTOL-MYERS SQUIBB COMPANY (US) | 1998-02-19 | — | — | WO | disclosed |
| WO-1998006277-A1 | NUTRITIONAL FORMULAS SUPPLEMENTED WITH NUCLEOTIDES, AND PROCESSES THEREOF | BRISTOL-MYERS SQUIBB COMPANY (US) | 1998-02-19 | — | — | WO | disclosed |